Login / Signup

Cardiovascular Disease Risk Factors and Metabolic Morbidity in a Longitudinal Study of Congenital Adrenal Hyperplasia.

Ahmed TorkyNinet SinaiiSmita JhaJay DesaiDiala El-MaoucheAshwini MallappaDeborah P Merke
Published in: The Journal of clinical endocrinology and metabolism (2021)
Patients with CAH develop metabolic morbidity at a young age associated with treatment-related and familial factors. Judicious use of glucocorticoid and mineralocorticoid is warranted.
Keyphrases
  • cardiovascular disease
  • risk factors
  • type diabetes
  • early onset
  • middle aged
  • coronary artery disease
  • combination therapy